Global Probenecid Market 2023-2030

    In Stock

    Coming Soon.




    Probenecid, also sold under the brand name Probalan, is a medication that increases uric acid excretion in the urine. It is primarily used in treating gout and hyperuricemia. Probenecid was developed as an alternative to caronamide to competitively inhibit renal excretion of some drugs, thereby increasing their plasma concentration and prolonging their effects.


    Probenecid is primarily used to treat gout and hyperuricemia. Probenecid is sometimes used to increase the concentration of some antibiotics and to protect the kidneys when given with cidofovir. Specifically, a small amount of evidence supports the use of intravenous cefazolin once rather than three times a day when it is combined with probenecid.


    It has also found use as a masking agent, potentially helping athletes using performance-enhancing substances to avoid detection by drug tests.


    Mild symptoms such as nausea, loss of appetite, dizziness, vomiting, headache, sore gums, or frequent urination are common with this medication. Life-threatening side effects such as thrombocytopenia, hemolytic anemia, leukemia and encephalopathy are extremely rare.


    Theoretically probenecid can increase the risk of uric acid kidney stones. Some of the important clinical interactions of probenecid include those with captopril, indomethacin, ketoprofen, ketorolac, naproxen, cephalosporins, quinolones, penicillins, methotrexate, zidovudine, ganciclovir, lorazepam, and acyclovir.


    In all these interactions, the excretion of these drugs is reduced due to probenecid, which in turn can lead to increased concentrations of these.




    Infographic: Probenecid Market, Probenecid Market Size, Probenecid Market Trends, Probenecid Market Forecast, Probenecid Market Risks, Probenecid Market Report, Probenecid Market Share


    The Global Probenecid market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    Glaxo Probenecid – PROBENECID belongs to a class of medication called uricosuric, primarily used to decrease blood uric acid levels in the body. It is used to treat Gout and Gouty arthritis (increased uric acid leading to inflammation).


    Gout is a painful type of inflammatory arthritis. It normally affects one joint at a time (often the big toe joint). This condition is caused by high uric acid levels.


    PROBENECID contains probenecid, which works by blocking urate tubular reabsorption, lowering serum urate levels. This prevents uric acid synthesis within the body without interfering with the necessary mechanisms of cells and the body.


    PROBENECID is not recommended for use in children below two years of age. It is advised not to drive vehicles or operate machines as PROBENECID can make the patient drowsy.





    1. How many Probenecid are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Probenecid and key vendor selection criteria
    3. Where is the Probenecid manufactured? What is the average margin per unit?
    4. Market share of Global Probenecid market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Probenecid in-house
    6. key predictions for next 5 years in Global Probenecid market
    7. Average B-2-B Probenecid market price in all segments
    8. Latest trends in Probenecid market, by every market segment
    9. The market size (both volume and value) of the Probenecid market in 2023-2030 and every year in between?
    10. Production breakup of Probenecid market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop